… coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus disease
2019 (COVID-19… -2 is crucial for defining the pathogenicity of COVID-19. In this study, we …

… of gut mucosal function and inflammation in the pathogenesis of COVID-19-related disease.
… in COVID-19 patients When comparing COVID-19 patients with elevated cardiac markers to …

… used for COVID-19 diagnosis and … in COVID-19 positive patients. In this observational
prospective study, we included 119 hospitalized COVID-19 positive patients and 15 COVID-19 …

… since the start of the coronavirus disease 2019 (COVID-19) pandemic. Several studies have
… organ failure in COVID-19 patients. The purpose of our study was to evaluate COVID-19-…

… these markers and the overall outcome of patients with COVID-19 disease. Inflammatory
markers have been reported to be predictors of mortality in patients with COVID-19 disease [6]. …

… COVID-19 could be detected by several clinical indicators including hematological,
immunological, biochemical, and inflammatory markers… in the development of COVID-19, to …

… In order to evaluate the risk of elevated levels of cardiac markers in COVID-19 patients as
early as possible, we established a prognosis prediction model based on levels of BNP, hs-TNI…

… Though we targeted specific immunological markers based on a literature review, our
study suggests a potential target without establishing if the marker is the culprit of the COVID-19-…

… as supporting evidence of a COVID-19 infection and as … as prognostic markers for
severe disease in COVID-19 cases [… in hospitalized COVID-19 patients with pneumonia [Citation3]. …

… Comparisons of COVID-19 and non-COVID-19 ARDS report comparable to lower initial
levels of endothelial injury markers, such as angiopoietin-2, in COVID-19 ARDS (18, 19). …